MedTrace Logo

Cancer DNA Detection in Blood and Urine

NCT02657863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2025-12-23

No results posted yet for this study

Summary

This study is being conducted to collect and analyze biospecimens (blood and urine) and clinical data from patients with prostate cancer as well as healthy volunteers to better understand the differences between cancer cells and normal tissues with the goal of developing a better way to detect and track the treatment of prostate cancer.

* These samples are being collected to conduct research to accomplish the goal of improving cancer therapies, biomarkers, and hopefully lead to more effective treatment of prostate cancer.
* The samples that you are providing as a patient with prostate cancer will be used in future research.
* Your biospecimens will be compared to the cancer and normal volunteer specimens from other participants to understand genetic differences between normal and cancer cells. Genetic material, including DNA and RNA, will be obtained from samples, stored, and used for evaluation.
* Clinical information and samples will be collected and stored for ongoing research. This is a necessity because improved diagnosis, prognosis and treatment of cancer in the future depend upon the ongoing analysis of basic research findings and clinical outcomes. This type of research may improve the lives of future patients with cancer.

Men between the ages of 18 and 100 with a diagnosis of cancer undergoing standard therapy with radiation may join.

Conditions

Interventions

PROCEDURE

Urine collection and blood draw

Sponsors & Collaborators

  • Patrick C Walsh Prostate Cancer Research Fund

    collaborator UNKNOWN

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Theodore DeWeese, M.D. · Johns Hopkin SKCCC

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2022-04-30
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657863 on ClinicalTrials.gov